These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 36038948)

  • 1. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
    Wang X; Chen T; Li C; Li W; Zhou X; Li Y; Luo D; Zhang N; Chen B; Wang L; Zhao W; Fu S; Yang Q
    J Hematol Oncol; 2022 Aug; 15(1):122. PubMed ID: 36038948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review.
    Wang H; Shan X; Peng Y; Zhou W
    Drug Dev Res; 2023 Aug; 84(5):805-814. PubMed ID: 37114737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
    Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
    Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
    Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
    Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer.
    Song R; Guo P; Ren X; Zhou L; Li P; Rahman NA; Wołczyński S; Li X; Zhang Y; Liu M; Liu J; Li X
    Mol Cancer; 2023 Jul; 22(1):104. PubMed ID: 37408008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
    Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
    Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
    Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
    Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircRNA_0044556 diminishes the sensitivity of triple‑negative breast cancer cells to adriamycin by sponging miR‑145 and regulating NRAS.
    Chen J; Shi P; Zhang J; Li Y; Ma J; Zhang Y; Liu H
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple-negative breast cancer by targeting miR-761/DACT2 signaling axis.
    Huang S; Xie J; Lei S; Fan P; Zhang C; Huang Z
    Mol Carcinog; 2023 Apr; 62(4):450-463. PubMed ID: 36562476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
    Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
    Tang H; Huang X; Wang J; Yang L; Kong Y; Gao G; Zhang L; Chen ZS; Xie X
    Mol Cancer; 2019 Feb; 18(1):23. PubMed ID: 30744636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.
    Foruzandeh Z; Dorabadi DG; Sadeghi F; Zeinali-Sehrig F; Zaefizadeh M; Rahmati Y; Alivand MR
    Mol Biol Rep; 2022 Oct; 49(10):9825-9840. PubMed ID: 35534586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    He R; Liu P; Xie X; Zhou Y; Liao Q; Xiong W; Li X; Li G; Zeng Z; Tang H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):145. PubMed ID: 29037220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
    Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
    Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis.
    Yu J; Shen W; Xu J; Gong B; Gao B; Zhu J
    Technol Cancer Res Treat; 2020; 19():1533033820950827. PubMed ID: 32938310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircSNX25 mediated by SP1 promotes the carcinogenesis and development of triple-negative breast cancer.
    Gao H; Tuluhong D; Li X; Zhu Y; Xu C; Wang J; Li H; Wang S; Ding W
    Cell Signal; 2023 Sep; 109():110776. PubMed ID: 37331414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis.
    Huang Y; Zheng S; Lin Y; Ke L
    Mol Cell Biol; 2021 Sep; 41(10):e0060920. PubMed ID: 34370552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Circ_0000977-Mediated Regulatory Network in Breast Cancer: A Potential Discriminative Biomarker for Triple-Negative Tumors.
    Darbeheshti F; Mansoori Y; Azizi-Tabesh G; Zolfaghari F; Kadkhoda S; Rasti A; Rezaei N; Shakoori A
    Biochem Genet; 2023 Aug; 61(4):1487-1508. PubMed ID: 36645554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.
    Li J; Ma M; Yang X; Zhang M; Luo J; Zhou H; Huang N; Xiao F; Lai B; Lv W; Zhang N
    Mol Cancer; 2020 Sep; 19(1):142. PubMed ID: 32917240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.